| dc.contributor.author | McDonald, Kerrie | |
| dc.contributor.author | Ha, Wendy | |
| dc.contributor.author | Nalkıran, Hatice Sevim | |
| dc.contributor.author | Khasraw, Mustafa | |
| dc.date.accessioned | 2020-12-19T19:49:56Z | |
| dc.date.available | 2020-12-19T19:49:56Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | McDonald, K., Ha, W., Nalkiran, H.S., Khasraw, M. (2016). Repurposing ibudilast in combination with temozolomide for glıoblastoma. Neuro-Oncology, 18, 67-67. | en_US |
| dc.identifier.issn | 1522-8517 | |
| dc.identifier.issn | 1523-5866 | |
| dc.identifier.uri | https://hdl.handle.net/11436/2362 | |
| dc.description | 21st Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology -- NOV 17-20, 2016 -- Scottsdale, AZ | en_US |
| dc.description | WOS: 000398604101198 | en_US |
| dc.description.abstract | Aims: Recurrence in patients with Glioblastoma (GBM) is
inevitable, even in patients with O-6-Methylguanine-DNA
Methyl Transferase (MGMT) methylation. | en_US |
| dc.description.sponsorship | Soc Neuro Oncol | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Oxford Univ Press Inc | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Repurposing ibudilast in combination with temozolomide for glıoblastoma | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | RTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
| dc.contributor.institutionauthor | Nalkıran, Hatice Sevim | |
| dc.identifier.volume | 18 | en_US |
| dc.identifier.startpage | 63 | en_US |
| dc.identifier.endpage | 63 | en_US |
| dc.relation.journal | Neuro-Oncology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
